Hong Kong Biotech Stocks Continue Strong Performance with Clover Bio-B Surging Over 12%

Deep News

09/01

Hong Kong biotech stocks maintained their upward momentum, with Clover Bio-B leading the gains with a surge of over 12%. Hua Medicine and Alphamab Oncology both climbed more than 9%, while XtalPi Holdings rose over 6%. Junshi Biosciences, WuXi Biologics, and BeiGene all advanced more than 4%.

Pacific Securities released a research note recommending investors pay attention to the incremental impact on the pharmaceutical sector from changes in market pricing power funding, particularly strategic positioning in AI healthcare and innovative drug investment strategies. At the industry level, the firm suggests monitoring: 1) Changes in Federal Reserve interest rate policy, 2) Marginal changes in investment and financing, 3) Gradual recovery in overseas demand, 4) China-US relations and geopolitical factors, 5) The rollout of detailed policies including medical insurance Category C catalog, commercial insurance, and comprehensive support policies for the innovative drug industry chain.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1143376945"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143376945\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143376945?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-01 10:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143376945","market":"us","top_or_hot":-1,"title":"Hong Kong Biotech Stocks Continue Strong Performance with Clover Bio-B Surging Over 12%","media":"Deep News","content":"<p>Hong Kong biotech stocks maintained their upward momentum, with Clover Bio-B leading the gains with a surge of over 12%. Hua Medicine and Alphamab Oncology both climbed more than 9%, while XtalPi Holdings rose over 6%. Junshi Biosciences, WuXi Biologics, and BeiGene all advanced more than 4%.</p>\n<p>Pacific Securities released a research note recommending investors pay attention to the incremental impact on the pharmaceutical sector from changes in market pricing power funding, particularly strategic positioning in AI healthcare and innovative drug investment strategies. At the industry level, the firm suggests monitoring: 1) Changes in Federal Reserve interest rate policy, 2) Marginal changes in investment and financing, 3) Gradual recovery in overseas demand, 4) China-US relations and geopolitical factors, 5) The rollout of detailed policies including medical insurance Category C catalog, commercial insurance, and comprehensive support policies for the innovative drug industry chain.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Biotech Stocks Continue Strong Performance with Clover Bio-B Surging Over 12%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Biotech Stocks Continue Strong Performance with Clover Bio-B Surging Over 12%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time smaller\">2025-09-01 10:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Hong Kong biotech stocks maintained their upward momentum, with Clover Bio-B leading the gains with a surge of over 12%. Hua Medicine and Alphamab Oncology both climbed more than 9%, while XtalPi Holdings rose over 6%. Junshi Biosciences, WuXi Biologics, and BeiGene all advanced more than 4%.</p>\n<p>Pacific Securities released a research note recommending investors pay attention to the incremental impact on the pharmaceutical sector from changes in market pricing power funding, particularly strategic positioning in AI healthcare and innovative drug investment strategies. At the industry level, the firm suggests monitoring: 1) Changes in Federal Reserve interest rate policy, 2) Marginal changes in investment and financing, 3) Gradual recovery in overseas demand, 4) China-US relations and geopolitical factors, 5) The rollout of detailed policies including medical insurance Category C catalog, commercial insurance, and comprehensive support policies for the innovative drug industry chain.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"YANG","symbol_name":"三倍沽空富時中國ETF-Direxion","start_time":0,"source_url":"","article_id":"1143376945","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143376945","pubTimestamp":1756692639,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Hong Kong biotech stocks maintained their upward momentum, with Clover Bio-B leading the gains with a surge of over 12%. Hua Medicine and Alphamab Oncology both climbed more than 9%, while XtalPi...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"YANG":"三倍做空富时中国ETF-Direxion","BK1161":"生物科技","HSTECH":"恒生科技指数","BK4614":"Manus概念股","HSCEI":"国企指数","02197":"三叶草生物-B","07226":"南方两倍做多恒科"},"translate_title":"香港生物科技股延续强劲表现三叶草生物-B大涨超12%","themeId":"c3254beb3708cecfea7110f8c44bea74","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02197":1,"HSTECH":1,"YANG":1,"07226":1,"HSCEI":1},"content_text":"Hong Kong biotech stocks maintained their upward momentum, with Clover Bio-B leading the gains with a surge of over 12%. Hua Medicine and Alphamab Oncology both climbed more than 9%, while XtalPi Holdings rose over 6%. Junshi Biosciences, WuXi Biologics, and BeiGene all advanced more than 4%.\nPacific Securities released a research note recommending investors pay attention to the incremental impact on the pharmaceutical sector from changes in market pricing power funding, particularly strategic positioning in AI healthcare and innovative drug investment strategies. At the industry level, the firm suggests monitoring: 1) Changes in Federal Reserve interest rate policy, 2) Marginal changes in investment and financing, 3) Gradual recovery in overseas demand, 4) China-US relations and geopolitical factors, 5) The rollout of detailed policies including medical insurance Category C catalog, commercial insurance, and comprehensive support policies for the innovative drug industry chain.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}